Effects of a ritonavir‐containing regimen on the pharmacokinetics of sirolimus or everolimus in healthy adult subjects by Jiuhong Zha, Qi Jiang, Betty B. Yao, Daniel E. Cohen, David C. Carter, Rajeev M. Menon

Get full text

Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens. by Aparna Vasanthakumar, Justin W Davis, Manal Abunimeh, Jonas Söderholm, Jiuhong Zha, Emily O Dumas, Daniel E Cohen, Jeffrey F Waring, Martin Lagging

Get full text

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in Patients With Hepatitis C Virus Genotype 1 or 4 Infection and Advanced Kidney Disease by Eric Lawitz, Edward Gane, Eric Cohen, John Vierling, Kosh Agarwal, Tarek Hassanein, Parvez S. Mantry, Paul J. Pockros, Michael Bennett, Nyingi Kemmer, Giuseppe Morelli, Jiuhong Zha, Deli Wang, Nancy S. Shulman, Daniel E. Cohen, K. Rajender Reddy

Get full text

Leveraging patient‐centric sampling for clinical drug development and decentralized clinical trials: Promise to reality by Katie F. Maass, Matthew D. Barfield, Mototsugu Ito, Christopher A. James, Olga Kavetska, Marc Kozinn, Parag Kumar, Maureen Lepak, Luc Alexis Leuthold, Wenkui Li, Dmitri Mikhailov, Shefali Patel, Nisha L. Perez, Deanne Jackson Rudd, Blisse Vakkalagadda, Tracy M. Williams, Jiuhong Zha, Xin Zhang, Melanie D. Anderson

Get full text

Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir and With or Without Ribavirin for Adolescents With HCV Genotype 1 or 4 by Daniel H. Leung, Stefan Wirth, Betty B. Yao, Rolando M. Viani, Regino P. Gonzalez‐Peralta, Maureen M. Jonas, Steven J. Lobritto, Michael R. Narkewicz, Etienne Sokal, Clàudia Fortuny, Evelyn K. Hsu, Antonio Del Valle‐Segarra, Jiuhong Zha, Lois Larsen, Li Liu, Diana L. Shuster, Daniel E. Cohen, Philip Rosenthal

Get full text